Efficacy of secukinumab in patients with hidradenitis suppurativa based on the international hidradenitis suppurativa severity scoring system (IHS4): A post hoc analysis of the SUNSHINE and SUNRISE trials

被引：0

作者：

Zouboulis, Christos C. ^{[1
,2
,3
,4
,5
,6
]}

Kyrgidis, Athanassios ^{[1
,7
]}

Alavi, Afsaneh ^{[1
,8
]}

Jemec, Gregor B. E. ^{[1
,9
]}

Martorell, Antonio ^{[1
,10
]}

Marzano, Angelo V. ^{[11
,12
]}

van der Zee, Hessel H. ^{[1
,13
]}

Muscianisi, Elisa ^{[14
]}

Kasparek, Torben ^{[15
]}

Bachhuber, Teresa ^{[16
]}

Wozniak, Magdalena B. ^{[16
]}

Ortmann, Christine-Elke ^{[15
]}

Lobach, Iryna ^{[15
]}

Ravichandran, Shoba ^{[14
]}

Tzellos, Thrasyvoulos ^{[1
,17
]}

机构：

[1] European Hidradenitis Suppurativa Fdn EHSF, Dessau, Germany

[2] Brandenburg Med Sch Theodor Fontane, Dessau, Germany

[3] Staedt Klinikum Dssau, Fac Hlth Sci Brandenburg, Dept Dermatol, Dessau, Germany

[4] Staedt Klinikum Dssau, Fac Hlth Sci Brandenburg, Dept Venereol, Dessau, Germany

[5] Staedt Klinikum Dssau, Fac Hlth Sci Brandenburg, Dept Allergol, Dessau, Germany

[6] Staedt Klinikum Dssau, Fac Hlth Sci Brandenburg, Dept Immunol, Dessau, Germany

[7] Aristotle Univ Thessaloniki, Papanikolaou Gen Hosp Thessaloniki, Dept Maxillofacial Surg, Thessaloniki, Greece

[8] Mayo Clin, Dept Dermatol, Rochester, MN USA

[9] Univ Copenhagen, Zealand Univ Hosp, Roskilde & Hlth Sci Fac, Dept Dermatol, Copenhagen, Denmark

[10] Hosp Manises, Dept Dermatol, Valencia, Spain

[11] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy

[12] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[13] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands

[14] Novartis Pharmaceut, E Hanover, NJ USA

[15] Novartis Pharma AG, Basel, Switzerland

[16] Novartis Ireland Ltd, Dublin, Ireland

[17] Nordland Hosp Trust, Dept Dermatol, Bodo, Norway

来源：

EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：27 / 28

页数：2

共 25 条

[21] Change of the IHS4 score as a measure of long-term Adalimumab efficacy in Hidradenitis Suppurativa (HS): A real-life cohort
Argyropoulou, M.
Avgoustou, C.
Kanni, T.
Giamarellos-Bourboulis, E.
EXPERIMENTAL DERMATOLOGY, 2018, 27 : 20 - 20
[22] Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial
Kimball, Alexa B.
Bechara, Falk G.
Badat, Aysha
Giamarellos-Bourboulis, Evangelos J.
Gottlieb, Alice B.
Jemec, Gregor B. E.
Reguiai, Ziad
Villani, Axel P.
Alarcon, Ivette
Bansal, Amita
Gasperoni, Francesca
Martin, Ruvie
Paguet, Bertrand
Uhlmann, Lorenz
Zouater, Hichem
Ravichandran, Shoba
Alavi, Afsaneh
BRITISH JOURNAL OF DERMATOLOGY, 2025, 192 (04) : 629 - 640
[23] Secukinumab in moderate to severe hidradenitis suppurativa: Week 16 results of hurley stage II and III from the sunshine and sunrise phase 3 randomized trials
Kimball, Alexa B.
Alavi, Afsaneh
Jemec, Gregor B. E.
Zouboulis, Christos C.
Wozniak, Magdalena B.
Uhlmann, Lorenz
Llobet-Martinez, Angela
Ravichandran, Shoba
Marzano, Angelo V.
Reguiai, Ziad
EXPERIMENTAL DERMATOLOGY, 2023, 32 : 25 - 26
[24] Validation of HS4 scoring system and development and validation of a novel scoring system to assess hidradenitis suppurativa severity
Tzellos, T.
EXPERIMENTAL DERMATOLOGY, 2017, 26 : 27 - 27
[25] Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
Kimball, Alexa B.
Jemec, Gregor B. E.
Alavi, Afsaneh
Reguiai, Ziad
Gottlieb, Alice B.
Bechara, Falk G.
Paul, Carle
Bourboulis, Evangelos J. Giamarellos
Villani, Axel P.
Schwinn, Andreas
Rueff, Franziska
Ramaya, Larisha Pillay
Reich, Adam
Lobo, Ines
Sinclair, Rodney
Passeron, Thierry
Martorell, Antonio
Mendes-Bastos, Pedro
Kokolakis, Georgios
Becherel, Pierre-Andre
Wozniak, Magdalena B.
Martinez, Angela Llobet
Wei, Xiaoling
Uhlmann, Lorenz
Passera, Anna
Keefe, Deborah
Martin, Ruvie
Field, Clarice
Chen, Li
Vandemeulebroecke, Marc
Ravichandran, Shoba
Muscianisi, Elisa
LANCET, 2023, 401 (10378): : 747 - 761

← 1 2 3 →